Blog
Two Small Changes, a Big Difference: How Czech Chemists Redesigned Vasopressin Into Desmopressin
Sometimes the cleverest peptide chemistry is the smallest. In Prague in the 1960s, a team led by Milan Zaoral and Frantisek Sorm took a nine-amino-acid hormone and changed just two things. Those two edits created desmopressin, one of the best-known peptide analogs ever made.
Key takeaways
- Vasopressin, a nine-amino-acid peptide, raises blood pressure and reduces urine output.
- Zaoral and Sorm removed the free amino group at the front, called deamination, and swapped L-arginine at position 8 for its mirror image, D-arginine.
- The changes weakened the blood pressure effect and strengthened the water-retention effect.
- The analog also survives longer in the body.
- Desmopressin was introduced in the late 1960s and remains a classic example of selective analog design.
A hormone with two jobs
Vincent du Vigneaud synthesized vasopressin and its close relative oxytocin in the early 1950s, work that earned him the Nobel Prize in Chemistry in 1955. The two hormones differ at only two of their nine amino acids, yet they act very differently. Oxytocin is best known for uterine and milk-ejection effects, which we cover in our oxytocin overview. Vasopressin tightens blood vessels and tells the kidney to hold on to water.
Researchers wanted a version that did only the second job, without the blood pressure rise.
Edit one: remove the amine
Vasopressin starts with a cysteine that has a free amino group, which enzymes called aminopeptidases attack. The Czech chemists made a version without that amino group, a change called deamination. This made the peptide more stable against the enzymes that begin chewing from the front.
Edit two: flip an amino acid
At position 8 vasopressin has L-arginine. Replacing it with D-arginine, its mirror image, reduced the activity on blood vessels dramatically while keeping the effect on the kidney. It also made the peptide harder for enzymes to cut. The result is called 1-deamino-8-D-arginine vasopressin, or DDAVP, now generally called desmopressin.
Mirror-image residues are a central tool for half-life engineering, and their effect is tested by methods such as chiral purity analysis.
Why selectivity matters
Two receptor families mediate vasopressin’s actions: one on blood vessels and one in the kidney. A peptide that favors the kidney receptor can be studied for that function alone. In pharmacology this is called selectivity, and it is usually the key to a useful analog. A related consideration appears in the melanocortin receptor family, where small changes shift the balance among receptor subtypes.
Route of delivery
Desmopressin is notable for its range of delivery routes, including nasal sprays and tablets, which became possible because the molecule is stable and potent. Nasal delivery of peptides is studied extensively, and our guides to permeation enhancers and mucociliary clearance explain the main hurdles.
The bottom line
Desmopressin shows that a peptide can be tuned with surgical precision. Two atoms of chemistry, in the right places, changed what the molecule does. For more on how analogs are designed and compared, browse our Research Library.
Related reading
- Oxytocin research overview
- Half-life engineering
- Nasal permeation enhancers
- Browse the full Research Library
Explore Lucid Aminos
- Shop all research compounds
- Read the lab reports (COA)
- Monthly Research Panel
- Frequently asked questions
- Partner program
- About Lucid Aminos
- Contact us
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.